These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25540373)

  • 21. Genetic variability of the envelope gene of Type D simian retrovirus-2 (SRV-2) subtypes associated with SAIDS-related retroperitoneal fibromatosis in different macaque species.
    Philipp-Staheli J; Marquardt T; Thouless ME; Bruce AG; Grant RF; Tsai CC; Rose TM
    Virol J; 2006 Mar; 3():11. PubMed ID: 16515713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The G-patch domain of Mason-Pfizer monkey virus is a part of reverse transcriptase.
    Křízová I; Hadravová R; Štokrová J; Günterová J; Doležal M; Ruml T; Rumlová M; Pichová I
    J Virol; 2012 Feb; 86(4):1988-98. PubMed ID: 22171253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activity of the Mason-Pfizer monkey virus fusion protein is modulated by single amino acids in the cytoplasmic tail.
    Song C; Micoli K; Hunter E
    J Virol; 2005 Sep; 79(18):11569-79. PubMed ID: 16140734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Capsid-dependent and -independent postentry restriction of primate lentivirus tropism in rodent cells.
    Hatziioannou T; Cowan S; Bieniasz PD
    J Virol; 2004 Jan; 78(2):1006-11. PubMed ID: 14694132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Basic residues in the Mason-Pfizer monkey virus gag matrix domain regulate intracellular trafficking and capsid-membrane interactions.
    Stansell E; Apkarian R; Haubova S; Diehl WE; Tytler EM; Hunter E
    J Virol; 2007 Sep; 81(17):8977-88. PubMed ID: 17596311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Type D retrovirus markers in healthy Africans from Guinea.
    Morozov VA; Lagaye S; Lyakh L; ter Meulen J
    Res Virol; 1996; 147(6):341-51. PubMed ID: 8958587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A dominant block to HIV-1 replication at reverse transcription in simian cells.
    Münk C; Brandt SM; Lucero G; Landau NR
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13843-8. PubMed ID: 12368468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimized method for isolation of immature intracytoplasmic retroviral particles from mammalian cells.
    Langerová H; Ruml T; Rumlová M
    J Virol Methods; 2017 Oct; 248():19-25. PubMed ID: 28619602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mason-Pfizer monkey virus (MPMV) constitutive transport element (CTE) functions in a position-dependent manner.
    Rizvi TA; Schmidt RD; Lew KA
    Virology; 1997 Sep; 236(1):118-29. PubMed ID: 9299624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NMR structure of the N-terminal domain of capsid protein from the mason-pfizer monkey virus.
    Macek P; Chmelík J; Krízová I; Kaderávek P; Padrta P; Zídek L; Wildová M; Hadravová R; Chaloupková R; Pichová I; Ruml T; Rumlová M; Sklenár V
    J Mol Biol; 2009 Sep; 392(1):100-14. PubMed ID: 19527730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retroviral restriction factors Fv1 and TRIM5alpha act independently and can compete for incoming virus before reverse transcription.
    Passerini LD; Keckesova Z; Towers GJ
    J Virol; 2006 Mar; 80(5):2100-5. PubMed ID: 16474118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of tunicamycin on cell fusion induced by Mason-Pfizer monkey virus.
    Chatterjee S; Bradac J; Hunter E
    J Virol; 1981 May; 38(2):770-6. PubMed ID: 7241666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resonance assignments of the myristoylated Y28F/Y67F mutant of the Mason-Pfizer monkey virus matrix protein.
    Doležal M; Hrabal R; Ruml T; Rumlová M
    Biomol NMR Assign; 2015 Oct; 9(2):229-33. PubMed ID: 25773138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rev/RRE-independent Mason-Pfizer monkey virus constitutive transport element-dependent propagation of SIVmac239 vectors using a single round of replication assay.
    Rizvi TA; Schmidt RD; Lew KA; Keeling ME
    Virology; 1996 Aug; 222(2):457-63. PubMed ID: 8806531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 1H, 13C, and 15N resonance assignment of the N-terminal domain of Mason-Pfizer monkey virus capsid protein, CA 1-140.
    Macek P; Zídek L; Rumlová M; Pichová I; Sklenár V
    Biomol NMR Assign; 2008 Jun; 2(1):43-5. PubMed ID: 19636921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interacting partners of M-PMV nucleocapsid-dUTPase.
    Németh-Pongrácz V; Snasel J; Rumlova M; Pichova I; Vértessy BG
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1197-200. PubMed ID: 17065090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conformational changes of the N-terminal part of Mason-Pfizer monkey virus p12 protein during multimerization.
    Knejzlík Z; Ulbrich P; Strohalm M; Lastůvková H; Kodícek M; Sakalian M; Ruml T
    Virology; 2009 Oct; 393(1):168-76. PubMed ID: 19699504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Susceptibility of human cultured cells to Mason-Pfizer monkey virus.
    Ogura H; Ocho M; Tanaka T; Oda T
    Gan; 1978 Jun; 69(3):413-5. PubMed ID: 97115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of Mason-Pfizer and simian type C viruses in the presence of 5-iododeoxyuridine and dexamethasone.
    Ahmed M; Schidlovsky G; Harewood KR; Manousos M; Mayyasi SA
    J Natl Cancer Inst; 1977 May; 58(5):1515-8. PubMed ID: 67214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potent restriction of HIV-1 and SIVmac239 replication by African green monkey TRIM5α.
    Coren LV; Trivett MT; Jain S; Ayala VI; Del Prete GQ; Ohlen C; Ott DE
    Retrovirology; 2015 Feb; 12():11. PubMed ID: 25809491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.